<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7935855/table_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 2</label>
  <p>Corroboration of the genetic overlap between PD and the blood levels of 25 lipids displaying significant genetic sharing with PD in phase I.</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-."/>
   <th colspan="3" rowspan="1" id="0-1-c">Phase I</th>
   <th colspan="3" rowspan="1" id="0-4-c">Phase II</th>
  </tr>
  <tr>
   <th colspan="1" rowspan="1" id="1-0-."/>
   <th colspan="1" rowspan="1" id="1-1-.">
    <i>P</i>
    <sub>T</sub>
   </th>
   <th colspan="1" rowspan="1" id="1-2-.">
    <i>P</i> value 
   </th>
   <th colspan="1" rowspan="1" id="1-3-.">
    <i>R</i>
    <sup>2</sup>
   </th>
   <th colspan="1" rowspan="1" id="1-4-.">
    <i>P</i>
    <sub>T</sub>
   </th>
   <th colspan="1" rowspan="1" id="1-5-.">
    <i>P</i> value 
   </th>
   <th colspan="1" rowspan="1" id="1-6-.">
    <i>R</i>
    <sup>2</sup>
   </th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>18:4n3</td>
   <td>0.3</td>
   <td>
    <b>1.34E-07</b>
   </td>
   <td>3.60E-03</td>
   <td>0.4</td>
   <td>4.82E-02</td>
   <td>3.77E-04</td>
  </tr>
  <tr>
   <td>20:3n3 or n6</td>
   <td>0.2</td>
   <td>
    <b>4.12E-07</b>
   </td>
   <td>3.30E-03</td>
   <td>0.5</td>
   <td>
    <b>3.38E-05</b>
   </td>
   <td>2.16E-03</td>
  </tr>
  <tr>
   <td>20:4n6</td>
   <td>0.3</td>
   <td>
    <b>4.51E-06</b>
   </td>
   <td>2.67E-03</td>
   <td>0.5</td>
   <td>
    <b>1.33E-06</b>
   </td>
   <td>2.99E-03</td>
  </tr>
  <tr>
   <td>20:5n3</td>
   <td>0.3</td>
   <td>
    <b>2.19E-09</b>
   </td>
   <td>4.66E-03</td>
   <td>0.5</td>
   <td>1.17E-03</td>
   <td>1.26E-03</td>
  </tr>
  <tr>
   <td>AC 2:0</td>
   <td>0.2</td>
   <td>
    <b>6.73E-06</b>
   </td>
   <td>2.53E-03</td>
   <td>0.5</td>
   <td>1.70E-02</td>
   <td>6.01E-04</td>
  </tr>
  <tr>
   <td>AC 8:1</td>
   <td>0.2</td>
   <td>
    <b>1.14E-05</b>
   </td>
   <td>2.40E-03</td>
   <td>0.5</td>
   <td>1.25E-02</td>
   <td>6.72E-04</td>
  </tr>
  <tr>
   <td>AC 14:2</td>
   <td>0.4</td>
   <td>
    <b>1.61E-15</b>
   </td>
   <td>1.07E-02</td>
   <td>0.1</td>
   <td>3.20E-03</td>
   <td>1.29E-03</td>
  </tr>
  <tr>
   <td>AC 18:0</td>
   <td>0.4</td>
   <td>
    <b>1.11E-06</b>
   </td>
   <td>3.30E-03</td>
   <td>0.1</td>
   <td>3.04E-02</td>
   <td>5.20E-04</td>
  </tr>
  <tr>
   <td>MAG 18:1</td>
   <td>0.4</td>
   <td>
    <b>1.08E-09</b>
   </td>
   <td>6.57E-03</td>
   <td>0.1</td>
   <td>4.78E-04</td>
   <td>2.01E-03</td>
  </tr>
  <tr>
   <td>TAG 44:1</td>
   <td>0.4</td>
   <td>
    <b>2.01E-06</b>
   </td>
   <td>1.02E-02</td>
   <td>0.4</td>
   <td>
    <b>1.02E-05</b>
   </td>
   <td>1.01E-02</td>
  </tr>
  <tr>
   <td>TAG 46:1</td>
   <td>0.4</td>
   <td>
    <b>1.37E-05</b>
   </td>
   <td>8.43E-03</td>
   <td>0.3</td>
   <td>
    <b>1.18E-05</b>
   </td>
   <td>9.90E-03</td>
  </tr>
  <tr>
   <td>TAG 46:2</td>
   <td>0.4</td>
   <td>
    <b>1.62E-06</b>
   </td>
   <td>1.04E-02</td>
   <td>0.3</td>
   <td>
    <b>1.03E-05</b>
   </td>
   <td>1.00E-02</td>
  </tr>
  <tr>
   <td>TAG 48:0</td>
   <td>0.4</td>
   <td>
    <b>1.91E-05</b>
   </td>
   <td>8.13E-03</td>
   <td>0.4</td>
   <td>
    <b>1.42E-06</b>
   </td>
   <td>1.21E-02</td>
  </tr>
  <tr>
   <td>PC aa 32:3</td>
   <td>0.4</td>
   <td>
    <b>1.85E-05</b>
   </td>
   <td>2.27E-03</td>
   <td>0.5</td>
   <td>
    <b>1.23E-04</b>
   </td>
   <td>1.80E-03</td>
  </tr>
  <tr>
   <td>PC ae 32:2</td>
   <td>0.4</td>
   <td>
    <b>1.52E-06</b>
   </td>
   <td>2.91E-03</td>
   <td>0.05</td>
   <td>2.58E-03</td>
   <td>1.05E-03</td>
  </tr>
  <tr>
   <td>PC ae 38:1</td>
   <td>0.5</td>
   <td>
    <b>5.14E-06</b>
   </td>
   <td>2.97E-03</td>
   <td>0.3</td>
   <td>2.19E-03</td>
   <td>1.24E-03</td>
  </tr>
  <tr>
   <td>PC ae 44:6</td>
   <td>0.4</td>
   <td>
    <b>8.19E-06</b>
   </td>
   <td>2.48E-03</td>
   <td>0.05</td>
   <td>2.79E-02</td>
   <td>4.90E-04</td>
  </tr>
  <tr>
   <td>LPC 16:0</td>
   <td>0.3</td>
   <td>
    <b>8.82E-07</b>
   </td>
   <td>3.05E-03</td>
   <td>0.001</td>
   <td>3.59E-03</td>
   <td>9.67E-04</td>
  </tr>
  <tr>
   <td>LPC 17:0</td>
   <td>0.5</td>
   <td>
    <b>8.52E-11</b>
   </td>
   <td>5.44E-03</td>
   <td>0.3</td>
   <td>9.83E-04</td>
   <td>1.28E-03</td>
  </tr>
  <tr>
   <td>LPC 18:0</td>
   <td>0.5</td>
   <td>
    <b>1.95E-19</b>
   </td>
   <td>1.06E-02</td>
   <td>0.001</td>
   <td>3.39E-03</td>
   <td>9.80E-04</td>
  </tr>
  <tr>
   <td>SM 26:0</td>
   <td>0.5</td>
   <td>
    <b>4.21E-27</b>
   </td>
   <td>1.73E-02</td>
   <td>0.3</td>
   <td>
    <b>3.00E-05</b>
   </td>
   <td>2.45E-03</td>
  </tr>
  <tr>
   <td>SM 26:1</td>
   <td>0.4</td>
   <td>
    <b>5.32E-06</b>
   </td>
   <td>2.59E-03</td>
   <td>0.001</td>
   <td>6.22E-04</td>
   <td>1.39E-03</td>
  </tr>
  <tr>
   <td>CE 20:5</td>
   <td>0.5</td>
   <td>
    <b>8.10E-07</b>
   </td>
   <td>1.10E-02</td>
   <td>0.5</td>
   <td>1.33E-02</td>
   <td>2.73E-03</td>
  </tr>
  <tr>
   <td>4-androsten-3beta,17beta-diol disulfate 1</td>
   <td>0.5</td>
   <td>
    <b>3.75E-07</b>
   </td>
   <td>3.32E-03</td>
   <td>0.3</td>
   <td>1.12E-03</td>
   <td>1.27E-03</td>
  </tr>
  <tr>
   <td>HDL-C</td>
   <td>0.2</td>
   <td>
    <b>1.02E-05</b>
   </td>
   <td>0.000841378</td>
   <td>0.05</td>
   <td>1.09E-01</td>
   <td>7.01E-05</td>
  </tr>
 </tbody>
 <tfoot>
  <p>
   <i>AC</i> acylcarnitine, 
   <i>MAG</i> monoacylglycerol, 
   <i>TAG</i> triacylglycerol, 
   <i>PC</i> phosphatidylcholine, 
   <i>PD</i> Parkinson’s disease, 
   <i>aa</i> diacyl, 
   <i>ae</i> acyl-alkyl, 
   <i>LPC</i> lysophosphatidylcholine, 
   <i>SM</i> sphingomyelin, 
   <i>CE</i> cholesterol ester, 
   <i>HDL</i> high-density lipoprotein. 
  </p>
  <p>Comparison of the most significant 
   <i>P</i> value threshold ( 
   <i>P</i>
   <sub>T</sub>), 
   <i>P</i> value, and explained variance ( 
   <i>R</i>
   <sup>2</sup>) for the results obtained in phases I and II. Significant results after Bonferroni correction (phase I: 
   <i>P</i> &lt; 1.93E-05; phase II: 
   <i>P</i> &lt; 2.86E-04), are highlighted in bold. In total, eight lipids show significant genetic sharing with PD in both phase I and II. 
  </p>
 </tfoot>
</table>
